Global pneumococcal sequence cluster lineage for invasive pneumococcal isolates in Denmark from summer 2019 to 2023.

Publication date: Jul 08, 2025

Denmark has monitored invasive pneumococcal diseases (IPD) for decades, observing shifts in serotype prevalence, partly due to pneumococcal conjugate vaccines in children. The COVID-19 pandemic and the Danish government’s 2020 vaccination program with the 23-valent pneumococcal polysaccharide vaccine (PPV23) for older adults further influenced IPD epidemiology. This study explores the dynamics of Global Pneumococcal Sequence Clusters (GPSCs) in Denmark from 2019 to 2023 using whole-genome sequencing (WGS) on IPD isolates from all age groups received at Statens Serum Institut (SSI). Serotyping, multilocus sequence typing (MLST), GPSC identification, and phylogenetic analysis to assess clonal relationships were conducted. Of the 1,999 sequenced isolates, representing 93. 3% of reported cases, 79 different GPSCs were identified, with GPSC3, GPSC12, and GPSC19 being dominant. GPSC3/ST53 (serotype 8) declined significantly from 24. 6% in 2019 to 14. 4% in 2023 (p 

Open Access PDF

Concepts Keywords
Denmark Adolescent
Genome Adult
Gpsc19 Aged
Pandemic Child
Vaccination Child, Preschool
COVID-19
Denmark
Denmark
Epidemiology
Female
GPSC
Humans
Infant
IPD
Male
Middle Aged
Multilocus Sequence Typing
Phylogeny
Pneumococcal Infections
Pneumococcal Vaccines
Pneumococcal Vaccines
Serogroup
Serotyping
Streptococcus pneumoniae
Streptococcus pneumoniae
Whole Genome Sequencing
Young Adult

Semantics

Type Source Name
disease MESH pneumococcal diseases
disease MESH COVID-19 pandemic
disease IDO pathogen
disease IDO blood
drug DRUGBANK Coenzyme M

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *